GoodRx Holdings, Inc. (GDRX) Stock

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc. is led by CEO Wendy Barnes, employs 738 people, headquartered in US, publicly traded since 2020.

GoodRx Holdings, Inc. (GDRX) stock trades at $3.54 with a market capitalization of $1.21B. The stock is valued at a price-to-earnings (P/E) ratio of 28.44, price-to-book of 1.44, price-to-sales of 1.21. Over the past 52 weeks the stock has ranged between $1.77 and $5.81, and currently trades 39.1% below its 52-week high.

On profitability, GoodRx Holdings, Inc. generates a return on equity (ROE) of 4.87%, return on capital employed of 7.51%, an operating margin of 10.92%, a net profit margin of 3.82%.

GoodRx Holdings, Inc. by the numbers, 2016–2025

Between 2016 and 2025 GoodRx Holdings, Inc. reported revenue of $99.0M rising to $797.0M, a change of +705.1% across 10 years. Compounded, revenue has grown 7.7% a year over five years, 1.3% over three, 0.6% over the last twelve months. Net profit rose to $30.0M.

Operating margin went from 19.0% in 2016 to 11.0% in 2025, a fall of 8.1 percentage points. The most recent net margin is 3.82%. On a trailing twelve-month basis to Jun '26, revenue is $785.0M and net profit $16.0M.

Borrowings rose from $46.0M to $543.0M, cash from operations was $168.0M in the latest year, positive in 8 of the last 10.

Return on equity has averaged -0.2% over five years, and was 4.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

GoodRx Holdings, Inc. (GDRX) — frequently asked questions